Drug Product
Regulatory, Tech Transfer & Support Services
Company Overview
About
Antheia Bio is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:United States
Founded:2006
Employees:1,691
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Global
Regulatory Approvals
Drug Approval 87QEWO
FDA · #APR-G7T7O80B · 2022-08-01
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-JHYDZGJK
Issued: 2020-04-04
Expires: 2025-04-19
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-XQUFUJB5
Issued: 2020-09-13
Expires: 2025-05-07
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-7WJHZBC6
Issued: 2020-04-02
Expires: 2025-11-03
Health Canada GMP
Health Canada
Cert #: CERT-PVK8UNKX
Issued: 2020-09-19
Expires: 2025-03-12
Loading CDMO intelligence...
Key facts about Antheia Bio
- Antheia Bio is headquartered in the United States.
- Antheia Bio was founded in 2006.
- Antheia Bio has 1,691 employees.
- Antheia Bio's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Antheia Bio
Directory pages this company appears in, each with the full list of matching manufacturers.